Methods and problems of the nosological analysis of mortality in the period of COVID-19 pandemic
https://doi.org/10.47093/2713-069X.2021.2.1.51-58
Abstract
The article discusses different approaches to assessing mortality during the COVID-19 pandemic. The analysis of international data shows that different countries use different approaches to assessing mortality from COVID-19 and the increase in mortality from all causes. The most probable reasons for the variability of the increase in mortality rates are the rate of spread of infection, the quality of isolation and quarantine measures, the commitment of the population to their implementation, the resource capacity of the healthcare system and the quality of medical care (both for the treatment of COVID-19 and other diseases), features of living conditions, socio-economic and political processes that are difficult to formalize (and therefore assess the contribution by methods of mathematical statistics). For a correct comparison of excess mortality rates, it will be necessary to calculate standardized indicators and compare data in five-year age groups.
In 2021, serious problems should be expected with the comparison of mortality rates in different countries from individual causes. The methodology for recording deaths from COVID-19 and other causes is not uniform at the global level, problems are associated with differences in approaches to determining the primary cause of death, difficulties in determining the cause of death if a patient has multimorbid pathology (especially without postmortem examination). A full-fledged analysis is possible only with transdisciplinary cooperation under the auspices of the WHO of doctors, mathematicians, economists, and information technology specialists.
About the Authors
O. M. Drapkina
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Oksana M. Drapkina – Dr. of Sci. (Medicine), Professor, Corresponding Member of the Russian Academy of Science, Director
I. V. Samorodskaya
National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Irina V. Samorodskaya – Dr. of Sci. (Medicine), Professor
Petroverigsky lane, 10, Moscow, 101990
E. P. Kakorina
Moscow Regional Research Clinical Institute named after M. F. Vladimirsky;
Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Ekaterina P. Kakorina – Dr. of Sci. (Medicine), Deputy Director, Moscow Regional Research Clinical Institute named after M.F. Vladimirsky; Professor, Institute for Leadership and Health Care Management, Sechenov First Moscow State Medical University
Shchepkina str., 61/2, Moscow, 129110;
Trubetskaya str., 8/2, Moscow, 119991
V. I. Perkhov
Central Research Institute of Healthcare Organization and Informatization of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Vladimir I. Perkhov – Dr. of Sci. (Medicine), Professor, Chief Researcher
Dobrolyubova str., 11, Moscow, 127254
References
1. Checchi F., Roberts L. Interpreting and using mortality data in humanitarian emergencies. Humanitarian Practice Network. 2005; 52: 38 p. http://www.redr.org/redr/support/TSS/doc/mortality_OliverMorgan.pdf (accessed 06.04.2021).
2. Savoia E., Lin L., Bernarnd D., et al. Public health system research in public health emergency preparedness in the United States (2009–2015): actionable knowledge base. American journal of public health. 2017; (107): e1–e6. https://doi.org/10.2105/AJPH.2017.304051 PMID: 28892437
3. Nielsen J., Mazick A., Andrews N., et al. Pooling European all-cause mortality: methodology and findings for the seasons 2008/2009 to 2010/2011. Epidemiol Infect. 2013; 141(9): 1996–2010. PMID: 23182146
4. Nielsen J., Vestergaard L.S., Richter L., et. al. European all-cause excess and infl ttributable mortality in the 2017/18 season: should the burden of infl B be reconsidered? Clin Microbiol Infect. 2019; 25(10): 1266–1276. https://doi.org/10.1016/j.cmi.2019.02.011
5. Vestergaard L.S., Nielsen J., Krause T.G., et. al. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017. Euro Surveill. 2017; 22(14): 30506. https://doi.org/10.2807/1560-7917.ES.2017.22.14.30506
6. 6 ECDC-WHO. Flu News Europe. Europe weekly influenza update. Week 5, 2017. https://www.ecdc.europa.eu/en/seasonal-influenza/surveillance-and-disease-data/flu-news-europe (accessed 06.04.2021).
7. EUROMOMO. Graphs and maps. https://www.euromomo.eu/graphs-and-maps/# (accessed 06.04.2021).
8. Spencer M.R., Ahmad F. Timeliness of death certificate data for mortality surveillance and provisional estimates. National Center for Health Statistics. 2016. http://www.cdc. gov/nchs/data/vsrr/report001.pdf.pdf icon (accessed 06.04.2021).
9. GCDL. Coronavirus Pandemic (COVID-19). https://ourworldindata.org/coronavirus (accessed 06.04.2021).
10. Federal State Statistics Service. Natural population movement in the context of the subjects of the Russian Federation for January–December 2020 years (in Russian). https://rosstat.gov.ru/storage/mediabank/TwbjciZH/edn12-2020.html (accessed 06.04.2021).
11. Office for National Statistics. Births, deaths and marriages. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages (accessed 06.04.2021).
12. Worldometer. Live statistics. https://www.worldometers.info/coronavirus/(accessed 06.04.2021).
13. WHO. Novel Coronavirus (2019-nCoV) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (accessed 06.04.2021).
14. Elfien J. Coronavirus (COVID-19) disease pandemic – Statistics & Facts. https://www.statista.com/topics/5994/the-coronavirus-disease-covid-19-outbreak/(accessed 06.04.2021).
15. Stang A., Standl F., Kowall B., et al. Excess mortality due to COVID-19 in Germany. Journal of Infection. 2020; 81(5): 797–801. https://doi.org/10.1016/j.jinf.2020.09.012
16. WHO. Emergency use ICD codes for COVID-19 disease outbreak. https://www.who.int/classifications/icd/covid19/en/(accessed 06.04.2021).
17. Crowcroft N., Majeed A. Improving the certification of death and the usefulness of routine mortality statistics. Clin Med. 2001; 1: 122–125. https://doi.org/10.7861/clinmedicine.1-2-122
18. Samorodskaya I.V., Zajrat’yanc O.V., Barbarash O.L., Bojcov S.A. Problems of estimating mortality rates from individual causes. Agreed expert opinion. Kardiologia. 2018; 58(9): 63–66 (in Russian). https://doi.org/https://doi.org/10.18087/cardio.2018.9.10178
19. CDC. New ICD-10-CM code for the 2019 Novel Coronavirus (COVID-19), October 1, 2020. https://www.cdc.gov/nchs/data/icd/Announcement-New-ICD-code-for-coronavi- rus-2-20-2020.pdf (accessed 06.04.2021).
20. EL PAÍS. Coronavirus Crisis in Spain: Spain’s Coronavirus Crisis: Why the Numbers Are Failing to Show the Full Picture. https://english.elpais.com/society/2020-04-05/spains-coronavirus-crisis-why-the-numbers-are-failing-to-show-the-full-picture.html (accessed 06.04.2021).
21. Catalan News. Why Is Spain as a Whole Reporting Fewer New Covid-19 Deaths Than Catalonia? https://www.catalannews.com/society-science/item/why-is-spain-as-a-whole-reporting-fewer-new-covid-19-deaths-than-catalonia (accessed 06.04.2021).
22. International Observatory of Human Rights. China, Russia, Brazil and the Underreporting of Covid-19 Cases. https://observatoryihr.org/news/china-russia-brazil-and-theunderreporting-of-covid-19-cases/(accessed 06.04.2021).
23. Deutsche Welle. Belgium’s Coronavirus (Over)Counting Controversy. https://www. dw.com/en/belgiums-coronavirus-overcounting-controversy/a-53660975 (accessed 06.04.2021).
24. Raleigh V. Deaths from Covid-19 (coronavirus): how are they counted and what do they show? The King’s Fund. https://www.kingsfund.org.uk/publications/deaths-covid-19 (accessed 06.04.2021).
25. Guidelines for coding and selecting the underlying condition in morbidity statistics and the initial cause in COVID-19-related mortality statistics. (in Russian). https://static-1. rosminzdrav.ru/system/attachments/attaches/000/050/527/original/27052020_MR_ STAT_1.pdf (accessed 06.04.2021).
26. Spencer E., Jefferson T., Brassey J., Heneghan C. When is covid covid? https://www.cebm.net/covid‐19/when‐is‐covid‐covid/(accessed 06.04.2021).
27. Boccia S., Ricciardi W., Ioannidis J.P.A. What other countries can learn from Italy during the COVID‐19 pandemic. JAMA Intern Med. 2020; 180: 987–988.https://doi.org/10.1001/jamainternmed.2020.14473
28. Ioannidis J.P.A., Axfors C., Contopoulos‐Ioannidis D.G. Population‐level COVID‐19 mortality risk for non‐elderly individuals overall and for non‐elderly individuals without underlying diseases in pandemic epicenters. Envir Res. 2020; 188: 109890. https://doi.org/10.1016/j.envres.2020.109890
29. Wadhera R.K., Shen C., Gondi S., et. al. Cardiovascular Deaths During the COVID-19 Pandemic in the United States. J Am Coll Cardiol. 2021; 77(2): 159–169. https://doi. org/10.1016/j.jacc.2020.10.055
30. Beaney T., Clarke J.M., Jain V., et al. Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide? J R Soc Med. 2020; 113(9): 329–334. https://doi.org/10.1177/0141076820956802 PMID: 32910871
31. Graham N.S.N., Junghans C., Downes R., et al. SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes. J Infect. 2020; 81: 411– 419. https://doi.org/10.1016/j.jinf.2020.05.073
32. Heldwein F.L., Loeb S., Wroclawski M.L., et al. A Systematic Review on Guidelines and Recommendations for Urology Standard of Care During the COVID-19 Pandemic. Eur Urol Focus. 2020; 6(5): 1070–1085. https://doi.org/10.1016/j.euf.2020.05.020
33. Lal S., Hayward C.S., De Pasquale C., et al. COVID-19 and Acute Heart Failure: Screening the Critically Ill – A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ). Heart Lung Circ. 2020; 29(7): e94–e98. https://doi.org/10.1016/j.hlc.2020.04.005
34. Chieffo A., Stefanini G.G., Price S., et al. EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. European Heart Journal. 2020; 41(19): 1839–1851. https://doi.org/10.1093/eurheartj/ehaa381
35. Hartnett K.P., Kite-Powell A., DeVies J., et al. Impact of the COVID-19 Pandemic on Emergency Department Visits – United States, January1, 2019 – May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69: 699–704. https://doi.org/10.15585/mmwr.mm6923e1
36. WHO. COVID-19 Significantly Impacts Health Services for Noncommunicable Diseases. https://www.who.int/news-room/detail/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases (accessed 06.04.2021).
37. COVID Effect’Leads to Fewer Heart Surgeries, More Patient Deaths Landmark study examines the pandemic’s impact on adult cardiac surgery in the US. https://www.sts.org/sites/default/fi ess-releases/COVID_Nguyen_FINALnoem.pdf (accessed 06.04.2021).
38. Woolf S.H., Chapman D.A., Sabo R.T., et al. Excess deaths from COVID‐19 and other causes, March‐April 2020. JAMA. 2020; 324(5): 510–513. https://doi.org/10.1001/jama.2020.11787
39. VanderWeele T.J. Challenges estimating total lives lost in COVID‐19 decisions: consideration of mortality related to unemployment, social isolation, and depression. JAMA. 2020; 324(5): 445–446. https://doi.org/10.1001/jama.2020.12187
40. De Filippo O., D’Ascenzo F., Angelini F., et al. Reduced rate of hospital admissions for ACS during covid‐19 outbreak in northern Italy. N Engl J Med. 2020; 383(1): 88–89. https://doi.org/10.1056/NEJMc2009166
41. Case A., Deaton A. Deaths of despair and the future of capitalism. Princeton, NJ. Princeton University Press. 2020; 12(4): 745–746. https://doi.org/10.1111/rsp3.12302
42. Wei J., Hou R., Zhang X., et al. The association of late‐life depression with all‐cause and cardiovascular mortality among community‐dwelling older adults: systematic review and meta‐analysis. Br J Psychiatry. 2019; 215(2): 449–455. https://doi.org/10.1192/bjp.2019.74
43. Elovainio M., Hakulinen C., Pulkki-Råback L., et al. Contribution of risk factors to excess mortality in isolated and lonely individuals: an analysis of data from the UK Biobank cohort study. Lancet Public Health. 2017; 4: e260–e266. https://doi.org/10.1016/S2468-2667(17)30075-0
44. Ayoubkhani D., Khunti K., Nafilyan V., et al. Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. medRxiv preprint. 2021. https://doi.org/10.1101/2021.01.15.21249885
Review
For citations:
Drapkina O.M., Samorodskaya I.V., Kakorina E.P., Perkhov V.I. Methods and problems of the nosological analysis of mortality in the period of COVID-19 pandemic. National Health Care (Russia). 2021;2(1):51-58. (In Russ.) https://doi.org/10.47093/2713-069X.2021.2.1.51-58
Views:
1231
Email this article 